Synthesis and evaluation of a series of pyridine and pyrimidine derivatives as type II c-Met inhibitors

In this study, a series of novel pyridine and pyrimidine-containing derivatives were designed, synthesized and biologically evaluated for their c-Met inhibitory activities. In the biological evaluation, half of the target compounds exhibited moderate to potent c-Met inhibitory activities. Among which, it is noteworthy that compounds 13d not only showed most potent c-Met inhibitory potency but also displayed excellent anti-proliferative activity (IC50 = 127 nM against EBC-1 cell line) as well as an acceptable kinase selectivity profile. Moreover, the western blot assay indicated that 13d inhibited c-Met phosphorylation in EBC-1 cells in a dose-dependent manner, with complete abolishment at 0.1 mM. All these experimental results suggested that 13d could be served as a promising lead compound for the development of anticancer agents. (C) 2017 Elsevier Ltd. All rights reserved.